- Parties: The applicant was Sandoz Canada Inc. The respondents were Merck Sharp & Dohme LLC, Merck Canada Inc., Pfizer, and Eisai R&D Management Co., Ltd.

- Subject Matter: This Federal Court matter involves a copyright infringement action brought by the Plaintiff against multiple pharmaceutical company defendants, including Pfizer Inc., Merck Sharp & Dohme LLC, Merck Canada Inc., and Eisai R&D Management Co., Ltd. The Plaintiff has tendered $15,000.00 into Court pursuant to Section 60(3) of the Patent Act, and the proceedings are being specially managed under Rules 383, 383.1, and 385 of the Federal Courts Rules. The case is ongoing.

- Date: The hearing was set on February 02, 2026.

- Venue: This was a federal case before the Federal Court.

- Amount: No financial award was specified.